56-yale felix blavatnik

The Turner lab at Yale has successfully treated 13 patients with phages so far. Now, the team has been awarded support from the Blavatnik Fund, which helps Yale scientists commercialize their discoveries. The support has made it possible for the team to launch the startup Felix Biotechnology, and to launch a phage clinical trial in partnership with the Yale Adult Cystic Fibrosis Center.